Letters to the Editor

Rapid and durable recovery of immune effector cells in myelofibrosis patients treated with momelotinib

Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London, UK; GKT School of Medical Education, King’s College London, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London
Weatherall Institute of Molecular Medicine, University of Oxford
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London, UK; School of Cancer and Pharmaceutical Sciences, King’s College London, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London, UK; School of Cancer and Pharmaceutical Sciences, King’s College London, London
Department of Clinical Haematology, Guy's and St Thomas’ NHS Foundation Trust, London, UK; School of Cancer and Pharmaceutical Sciences, King’s College London, London
Haematologica Early view Sep 25, 2025 https://doi.org/10.3324/haematol.2025.288515